Nicole Beydon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicole Beydon has a total of 291 co-authors. Here are the top co-authors by number of shared publications:
- Jessica Taytard
Sorbonne Université, APHP, Hôpital Armand Trousseau, Unité Fonctionnelle d'Explorations Fonctionnelles Respiratoire et Somnologie Paris Île‐de‐France France
10 shared publications - Jane S. Lucas
Clinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK
7 shared publications - June Kehlet Marthin
National Danish PCD Centre, Paediatric Pulmonary Service, Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
6 shared publications - Christophe Delclaux
Université Paris‐Cité, AP‐HP, Hôpital Robert Debré, Service de Physiologie Pédiatrique‐Centre du Sommeil, INSERM NeuroDiderot Paris France
5 shared publications - Harriet Corvol
Inserm U938, Centre de Recherche Saint‐Antoine (CRSA), Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Trousseau, Service de Pneumologie Pédiatrique Sorbonne Université Paris France
5 shared publications Jessica Taytard
Sorbonne Université, APHP, Hôpital Armand Trousseau, Unité Fonctionnelle d'explorations fonctionnelles respiratoire et somnologie; INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France
5 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (11)
A Delphi‐Based Item Set for Pre‐Test Asthma Probability Assessment in Children Undergoing Methacholine Challenge Test
Objective: To select, through a Delphi consensus process, the clinical items most relevant to pre‐test probability of asthma (PTPA) in children undergoing methacholine challenge test (MCT) and to explore their association with expert‐estimated PTPA. Working Hypothesis: Delphi‐selected items are associated with PTPA estimated independently by pediatric pulmonologists. Study Design: Three‐round e‐Delphi, followed by a retrospective analysis of item association with expert‐estimated PTPA. Patient‐subject selection: A database of 92 children referred for MCT at a tertiary center. Methodology: A steering committee proposed 11 candidate items, rated by 23 experts (consensus threshold ≥ 80%). Five pediatric pulmonologists, blinded to MCT results and not involved in the Delphi, independently estimated PTPA from clinical history. Agreement was assessed with intraclass correlation coefficients (ICC). Associations between retained items and mean PTPA were assessed using a multivariable linear regression. Results: Ten items were retained (nine reached consensus; pneumonia/atelectasis was retained by steering‐committee judgment). Single‐rater ICC was 0.78 (95% CI 0.70–0.85); average‐measures ICC was 0.95 (95% CI 0.92–0.97). Multivariable linear regression retained all ten items; each positively associated with PTPA. The strongest associations were seen with wheezing after age 3 years (β 15, 95% CI 7.4–23), wheezing within the last 3 years (β 14, 95% CI 6.4–22) and complete response to anti‐asthma treatment with relapse after treatment cessation (β 34, 95% CI 27–41). Conclusion: Delphi consensus identified ten clinically relevant items, all associated with expert‐estimated PTPA. As the outcome was expert judgement rather than confirmed asthma, diagnostic value remains unestablished; outcome‐based studies are needed.
- 3 November 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (11)
Open AccessA Delphi‐Based Item Set for Pre‐Test Asthma Probability Assessment in Children Undergoing Methacholine Challenge Test
Objective: To select, through a Delphi consensus process, the clinical items most relevant to pre‐test probability of asthma (PTPA) in children undergoing methacholine challenge test (MCT) and to explore their association with expert‐estimated PTPA. Working Hypothesis: Delphi‐selected items are associated with PTPA estimated independently by pediatric pulmonologists. Study Design: Three‐round e‐Delphi, followed by a retrospective analysis of item association with expert‐estimated PTPA. Patient‐subject selection: A database of 92 children referred for MCT at a tertiary center. Methodology: A steering committee proposed 11 candidate items, rated by 23 experts (consensus threshold ≥ 80%). Five pediatric pulmonologists, blinded to MCT results and not involved in the Delphi, independently estimated PTPA from clinical history. Agreement was assessed with intraclass correlation coefficients (ICC). Associations between retained items and mean PTPA were assessed using a multivariable linear regression. Results: Ten items were retained (nine reached consensus; pneumonia/atelectasis was retained by steering‐committee judgment). Single‐rater ICC was 0.78 (95% CI 0.70–0.85); average‐measures ICC was 0.95 (95% CI 0.92–0.97). Multivariable linear regression retained all ten items; each positively associated with PTPA. The strongest associations were seen with wheezing after age 3 years (β 15, 95% CI 7.4–23), wheezing within the last 3 years (β 14, 95% CI 6.4–22) and complete response to anti‐asthma treatment with relapse after treatment cessation (β 34, 95% CI 27–41). Conclusion: Delphi consensus identified ten clinically relevant items, all associated with expert‐estimated PTPA. As the outcome was expert judgement rather than confirmed asthma, diagnostic value remains unestablished; outcome‐based studies are needed.
- 14 August 2026
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
Impedance pneumography to explore bronchial obstruction in young infants born moderate-late preterm: a cohort study
Background: Wheezing, a symptom reflecting bronchial obstruction, is frequently reported in preterm-born infants. No objective and reliable tool is available to assert this diagnosis with minimal patient cooperation. Nocturnal tidal breathing measurements by impedance pneumography (IP) provide expiratory variability index (EVI) and the ratio of time to peak tidal expiratory flow to total expiration (tPTEF/tE) which are reduced in bronchial obstruction and may address this gap. Aims: To evaluate the application of IP measurements in a cohort of preterm-born infants. Methods: Home measurements were performed over two consecutive nights in infants (median (IQR) gestational age 34+4 weeks (33+1; 35+2)), around ages 3, 6 and 12 months. EVI and tPTEF/tE were derived from successful recordings (≥4 hours undisturbed). Measurements in term-born infants <14 months served as reference. Results: In total 372 night-recordings were obtained from 97 preterm infants. Success rates were 15%, 93% and 91% in infants aged 9 months, respectively. Explorative analyses showed EVI decreased during wheezing episodes from 14.4 (95% CI 13.2 to 15.7) to 9.6 (95% CI 5.6 to 13.5). Both EVI and tPTEF/tE tended to be lower in preterm than in term infants: EVI 14.6 (95% CI 13.5 to 15.8) versus 16.3 (95% CI 15.0 to 17.6) and tPTEF/tE 0.160 (95% CI 0.142 to 0.177) versus 0.187 (95% CI 0.158 to 0.216) Conclusions: Home IP measurement in preterm-born infants is moderately feasible, with improving success in older infants. Differences in EVI and tPTEF/tE by gestational maturity and during wheezing episodes indicate that IP provides clinically relevant information on airway obstruction, supporting its potential for research and future clinical use.
- 14 August 2026
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
Impedance pneumography to explore bronchial obstruction in young infants born moderate-late preterm: a cohort study
Background: Wheezing, a symptom reflecting bronchial obstruction, is frequently reported in preterm-born infants. No objective and reliable tool is available to assert this diagnosis with minimal patient cooperation. Nocturnal tidal breathing measurements by impedance pneumography (IP) provide expiratory variability index (EVI) and the ratio of time to peak tidal expiratory flow to total expiration (tPTEF/tE) which are reduced in bronchial obstruction and may address this gap. Aims: To evaluate the application of IP measurements in a cohort of preterm-born infants. Methods: Home measurements were performed over two consecutive nights in infants (median (IQR) gestational age 34+4 weeks (33+1; 35+2)), around ages 3, 6 and 12 months. EVI and tPTEF/tE were derived from successful recordings (≥4 hours undisturbed). Measurements in term-born infants <14 months served as reference. Results: In total 372 night-recordings were obtained from 97 preterm infants. Success rates were 15%, 93% and 91% in infants aged 9 months, respectively. Explorative analyses showed EVI decreased during wheezing episodes from 14.4 (95% CI 13.2 to 15.7) to 9.6 (95% CI 5.6 to 13.5). Both EVI and tPTEF/tE tended to be lower in preterm than in term infants: EVI 14.6 (95% CI 13.5 to 15.8) versus 16.3 (95% CI 15.0 to 17.6) and tPTEF/tE 0.160 (95% CI 0.142 to 0.177) versus 0.187 (95% CI 0.158 to 0.216) Conclusions: Home IP measurement in preterm-born infants is moderately feasible, with improving success in older infants. Differences in EVI and tPTEF/tE by gestational maturity and during wheezing episodes indicate that IP provides clinically relevant information on airway obstruction, supporting its potential for research and future clinical use.
- Open Access
- 13 June 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (6) , e71700
Impedance Pneumography in Healthy and Sick Children Aged Between 2 and 35 Months
Rational: Impedance pneumography (IP) non‐invasively records tidal breathing flow‐volume curves over long durations. It measures the ratio of time to peak tidal expiratory flow relative to the total expiration time (T PTEF /T E ) and the Expiratory Variability Index (EVI), which assesses the variability of expiratory flow in the early phase of expiration with a decrease in case of clinical symptoms of bronchial obstruction. Objective: To establish reference values for EVI and T PTEF /T E , recorded at home during sleep using IP. Methods: We conducted a bi‐centre prospective study to recorded EVI and T PTEF /T E over at least 4 h of sleep, using IP measurement Ventica® (Icare Finland Oy, Finland), in healthy and sick (non‐wheezy and wheezy) children, aged 2 to 35 months. Results: Among the 67 healthy children included, 59 were successfully recorded by parents (median [Q1; Q3] (range) age 15.4 [8.6; 26.0] (2.3−35.9) months) and showed median [Q1; Q3] (5th; 95th percentiles) EVI of 16.7 [14.9; 18.9] (12.7; 20.7); and T PTEF /T E ( n = 51) of 0.18 [0.16; 0.22] (0.13; 0.26). In 9 non‐wheezy children with respiratory symptoms and 12 wheezers, EVI (13.5 [9.6; 14.6] and 7.0 [6.0; 12.5], respectively) and T PTEF /T E (0.16 [0.13; 0.18] and 0.12 [0.09; 0.18], respectively) were significantly lower compared to healthy. The values of EVI and T PTEF /T E in 68 healthy and sick children with both measurements (12 missing data) were concordant (> or < 5th percentile) in 62 cases (91%). Conclusions: We provide reference values of EVI and T PTEF /T E measured at home by parents using IP in young children. IP shows lower values in wheezy and non‐wheezy sick young children.
- 13 June 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (6) , e71700
Open AccessImpedance Pneumography in Healthy and Sick Children Aged Between 2 and 35 Months
Rational: Impedance pneumography (IP) non‐invasively records tidal breathing flow‐volume curves over long durations. It measures the ratio of time to peak tidal expiratory flow relative to the total expiration time (T PTEF /T E ) and the Expiratory Variability Index (EVI), which assesses the variability of expiratory flow in the early phase of expiration with a decrease in case of clinical symptoms of bronchial obstruction. Objective: To establish reference values for EVI and T PTEF /T E , recorded at home during sleep using IP. Methods: We conducted a bi‐centre prospective study to recorded EVI and T PTEF /T E over at least 4 h of sleep, using IP measurement Ventica® (Icare Finland Oy, Finland), in healthy and sick (non‐wheezy and wheezy) children, aged 2 to 35 months. Results: Among the 67 healthy children included, 59 were successfully recorded by parents (median [Q1; Q3] (range) age 15.4 [8.6; 26.0] (2.3−35.9) months) and showed median [Q1; Q3] (5th; 95th percentiles) EVI of 16.7 [14.9; 18.9] (12.7; 20.7); and T PTEF /T E ( n = 51) of 0.18 [0.16; 0.22] (0.13; 0.26). In 9 non‐wheezy children with respiratory symptoms and 12 wheezers, EVI (13.5 [9.6; 14.6] and 7.0 [6.0; 12.5], respectively) and T PTEF /T E (0.16 [0.13; 0.18] and 0.12 [0.09; 0.18], respectively) were significantly lower compared to healthy. The values of EVI and T PTEF /T E in 68 healthy and sick children with both measurements (12 missing data) were concordant (> or < 5th percentile) in 62 cases (91%). Conclusions: We provide reference values of EVI and T PTEF /T E measured at home by parents using IP in young children. IP shows lower values in wheezy and non‐wheezy sick young children.
- 4 June 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 67 (6) , 2600300
Nasal nitric oxide during tidal breathing: closing the diagnostic gap for primary ciliary dyskinesia in young children
- 4 June 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 67 (6) , 2600300
Nasal nitric oxide during tidal breathing: closing the diagnostic gap for primary ciliary dyskinesia in young children
- Open Access
- 16 September 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (9) , e71295
Detecting Impaired Lung Growth Using the Conditional Change Score of FEV 1 in an Open Cohort of Children With Asthma
Background: It has been suggested that a quarter of children with asthma show impaired lung growth, with better initial function as a risk factor. A conditional change score (CCS) for FEV 1 that is independent of the initial FEV 1 and that takes into account the time interval between the measurements has been proposed, a value < −1.96 being predictive of impaired growth. Objective: To evaluate whether the use of the CCS allows the identification of a subgroup of children with asthma that has an impaired lung growth, and to identify the risk factors of impaired growth. Methods: We reanalyzed the data of 295 children with confirmed asthma (199 boys) who had undergone at least 10 spirometry tests from the age of 8 who were selected from a single‐center open cohort. The annualized rate of change (slope) for prebronchodilator FEV 1 (percent predicted) was estimated for each participant. Using the first and last visit of follow‐up, the CCS was calculated. Results: In total, 46 children (16%, 95% confidence interval: 12–20) followed up for a median duration of 6.5 years [interquartile: 5.7–7.3] exhibited an impaired lung growth. The CCS correlated with the standard deviation of individual slopes (FEV 1 variability criterion: R = 0.21; p < 0.001), the z ‐score of FEV 1 at first visit ( R = −0.22; p < 0.001), and the body mass index at final visit ( R = 0.16; p = 0.005), which remained independently associated with the CCS. Conclusion: We confirm that some children with asthma (16%) show impaired lung growth with better initial lung function and decreased FEV 1 variability as risk factors.
- 16 September 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (9) , e71295
Open AccessDetecting Impaired Lung Growth Using the Conditional Change Score of FEV 1 in an Open Cohort of Children With Asthma
Background: It has been suggested that a quarter of children with asthma show impaired lung growth, with better initial function as a risk factor. A conditional change score (CCS) for FEV 1 that is independent of the initial FEV 1 and that takes into account the time interval between the measurements has been proposed, a value < −1.96 being predictive of impaired growth. Objective: To evaluate whether the use of the CCS allows the identification of a subgroup of children with asthma that has an impaired lung growth, and to identify the risk factors of impaired growth. Methods: We reanalyzed the data of 295 children with confirmed asthma (199 boys) who had undergone at least 10 spirometry tests from the age of 8 who were selected from a single‐center open cohort. The annualized rate of change (slope) for prebronchodilator FEV 1 (percent predicted) was estimated for each participant. Using the first and last visit of follow‐up, the CCS was calculated. Results: In total, 46 children (16%, 95% confidence interval: 12–20) followed up for a median duration of 6.5 years [interquartile: 5.7–7.3] exhibited an impaired lung growth. The CCS correlated with the standard deviation of individual slopes (FEV 1 variability criterion: R = 0.21; p < 0.001), the z ‐score of FEV 1 at first visit ( R = −0.22; p < 0.001), and the body mass index at final visit ( R = 0.16; p = 0.005), which remained independently associated with the CCS. Conclusion: We confirm that some children with asthma (16%) show impaired lung growth with better initial lung function and decreased FEV 1 variability as risk factors.
- Open Access
- 28 August 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (6)
Reversibility in plethysmographic airway and specific airway resistance in children
Background: Plethysmographic airway resistance ( R aw ) and specific airway resistance (s R aw ) are widely used to assess baseline lung function and bronchodilator reversibility in children unable to perform spirometry. However, no consensus exists on cut-offs for significant reversibility. Methods: We conducted a retrospective study on a large cohort of asthmatic children tested during panting without electronic thermal compensation, to determine optimal R aw and s R aw cut-offs for detecting significant forced expiratory volume in 1 s (FEV 1 ) reversibility. A smaller cohort undergoing tidal breathing plethysmography with electronic thermal compensation was also analysed. Results: From 2436 tests without thermal compensation, receiver operating characteristic curve analysis identified cut-offs of −34.4% ( R awtot ) and −36.0% (s R awtot ) from baseline to detect significant FEV 1 reversibility, with sensitivities of 70% (95% CI 65–74%) and 72% (95% CI 67–76%) and specificities of 70% (95% CI 68–72%) and 73% (95% CI 71–75%), respectively. Expressing reversibility as a percentage of predicted did not improve accuracy, but required larger cut-offs (−42.6% for R awtot , −56.1% for s R awtot ) and increased the influence of baseline value. In the 106 tests performed using electronic thermal compensation, R awtot/eff and s R awtot/eff cut-offs were lower than that without electronic thermal compensation (−25% of baseline) with sensitivities and specificities ranging from 63% to 70%. Conclusion: R awtot and s R awtot reversibility effectively identify FEV 1 reversibility with cut-offs around −35% of the baseline value, showing no added benefit when using larger cut-offs expressed as a percentage of the predicted value. When electronic thermal compensation is applied, it may necessitate lower cut-offs of −25% of the baseline, compared to those determined without it.
- 28 August 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (6)
Open AccessReversibility in plethysmographic airway and specific airway resistance in children
Background: Plethysmographic airway resistance ( R aw ) and specific airway resistance (s R aw ) are widely used to assess baseline lung function and bronchodilator reversibility in children unable to perform spirometry. However, no consensus exists on cut-offs for significant reversibility. Methods: We conducted a retrospective study on a large cohort of asthmatic children tested during panting without electronic thermal compensation, to determine optimal R aw and s R aw cut-offs for detecting significant forced expiratory volume in 1 s (FEV 1 ) reversibility. A smaller cohort undergoing tidal breathing plethysmography with electronic thermal compensation was also analysed. Results: From 2436 tests without thermal compensation, receiver operating characteristic curve analysis identified cut-offs of −34.4% ( R awtot ) and −36.0% (s R awtot ) from baseline to detect significant FEV 1 reversibility, with sensitivities of 70% (95% CI 65–74%) and 72% (95% CI 67–76%) and specificities of 70% (95% CI 68–72%) and 73% (95% CI 71–75%), respectively. Expressing reversibility as a percentage of predicted did not improve accuracy, but required larger cut-offs (−42.6% for R awtot , −56.1% for s R awtot ) and increased the influence of baseline value. In the 106 tests performed using electronic thermal compensation, R awtot/eff and s R awtot/eff cut-offs were lower than that without electronic thermal compensation (−25% of baseline) with sensitivities and specificities ranging from 63% to 70%. Conclusion: R awtot and s R awtot reversibility effectively identify FEV 1 reversibility with cut-offs around −35% of the baseline value, showing no added benefit when using larger cut-offs expressed as a percentage of the predicted value. When electronic thermal compensation is applied, it may necessitate lower cut-offs of −25% of the baseline, compared to those determined without it.
- 30 July 2025
- Published by BMJ in Archives of Disease in Childhood
- Vol. 111 (1) , 21-26
Hypoxaemia definition in childhood based on arterial oxygen saturation obtained with a pulse oximeter: a retrospective study
Objective: Using normal pulse oximetry (SpO 2 ) values as basis, an oxygen saturation 2 associated with hypoxaemia, the prevalence of SpO 2 2 recordings, and further recorded pulmonary function test (PFT) indices (z-scores of forced expiratory volume at 1 s (FEV 1 ), forced vital capacity (FVC), FEV 1 /FVC and total lung capacity) of visits with SpO 2 2 overestimated arterialised saturation (bias: +1.3%, precision: ±1.1%). The 20 ABGs with SpO 2 ≤95% showed hypoxaemia (z-score of arterialised pressure of O 2 <−1.96), while 48/74 (65%) ABGs with SpO 2 of 96% or 97% showed hypoxaemia. Three thousand eight hundred twenty-four PFTs were recorded in 2641 children (1186 girls, 1455 boys) with a mean age (±SD) of 12.3±3.5 years. The prevalence of SpO 2 2 ≤95% and all had ventilatory defects (based on international definitions of PFT). Conclusions: An oxygen saturation ≤95%, using the Masimo oximeter, is indicative of hypoxaemia and PFT abnormalities, while oxygen saturation of 96% or 97% indicates possible hypoxaemia. Thus, chronic respiratory insufficiency can confidently be diagnosed if repeated SpO 2 is ≤95% using the Masimo oximeter.
- 30 July 2025
- Published by BMJ in Archives of Disease in Childhood
- Vol. 111 (1) , 21-26
Hypoxaemia definition in childhood based on arterial oxygen saturation obtained with a pulse oximeter: a retrospective study
Objective: Using normal pulse oximetry (SpO 2 ) values as basis, an oxygen saturation 2 associated with hypoxaemia, the prevalence of SpO 2 2 recordings, and further recorded pulmonary function test (PFT) indices (z-scores of forced expiratory volume at 1 s (FEV 1 ), forced vital capacity (FVC), FEV 1 /FVC and total lung capacity) of visits with SpO 2 2 overestimated arterialised saturation (bias: +1.3%, precision: ±1.1%). The 20 ABGs with SpO 2 ≤95% showed hypoxaemia (z-score of arterialised pressure of O 2 <−1.96), while 48/74 (65%) ABGs with SpO 2 of 96% or 97% showed hypoxaemia. Three thousand eight hundred twenty-four PFTs were recorded in 2641 children (1186 girls, 1455 boys) with a mean age (±SD) of 12.3±3.5 years. The prevalence of SpO 2 2 ≤95% and all had ventilatory defects (based on international definitions of PFT). Conclusions: An oxygen saturation ≤95%, using the Masimo oximeter, is indicative of hypoxaemia and PFT abnormalities, while oxygen saturation of 96% or 97% indicates possible hypoxaemia. Thus, chronic respiratory insufficiency can confidently be diagnosed if repeated SpO 2 is ≤95% using the Masimo oximeter.
- Open Access
- 1 April 2025
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 21 (2) , 240230
Nasal nitric oxide measurement for the diagnosis of primary ciliary dyskinesia: summary of the European Respiratory Society technical standard
Nasal nitric oxide (nNO) measurement is important in the primary ciliary dyskinesia (PCD) diagnostic pathway because levels are consistently very low in most patients. Machine type, environmental factors, respiratory manoeuvres and report interpretation are fundamental considerations when performing nNO testing. A European Respiratory Society Task Force recently published standards for testing which we summarise and discuss in this article. There are two main types of nNO machines: chemiluminescence and electrochemical analysers. Chemiluminescence analysers are highly accurate, reliable, real-time and have been validated in multicentre studies but are less portable and more expensive to purchase and maintain in comparison to electrochemical devices. Several factors may influence nNO levels and need to be addressed during patient preparation for testing. Factors including acute viral infections and nose bleeds may contribute to falsely low nNO levels, whereas high ambient NO levels may falsely increase nNO. Tidal breathing, breath-hold and exhalation against resistance are the three main respiratory manoeuvres used in nNO sampling and require a minimal, modest and high level of patient cooperation respectively. Finally, standardised reporting of nNO testing and the correct interpretation helps clinicians to formulate an appropriate clinical plan towards an accurate PCD diagnosis.
- 1 April 2025
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 21 (2) , 240230
Open AccessNasal nitric oxide measurement for the diagnosis of primary ciliary dyskinesia: summary of the European Respiratory Society technical standard
Nasal nitric oxide (nNO) measurement is important in the primary ciliary dyskinesia (PCD) diagnostic pathway because levels are consistently very low in most patients. Machine type, environmental factors, respiratory manoeuvres and report interpretation are fundamental considerations when performing nNO testing. A European Respiratory Society Task Force recently published standards for testing which we summarise and discuss in this article. There are two main types of nNO machines: chemiluminescence and electrochemical analysers. Chemiluminescence analysers are highly accurate, reliable, real-time and have been validated in multicentre studies but are less portable and more expensive to purchase and maintain in comparison to electrochemical devices. Several factors may influence nNO levels and need to be addressed during patient preparation for testing. Factors including acute viral infections and nose bleeds may contribute to falsely low nNO levels, whereas high ambient NO levels may falsely increase nNO. Tidal breathing, breath-hold and exhalation against resistance are the three main respiratory manoeuvres used in nNO sampling and require a minimal, modest and high level of patient cooperation respectively. Finally, standardised reporting of nNO testing and the correct interpretation helps clinicians to formulate an appropriate clinical plan towards an accurate PCD diagnosis.
- Open Access
- 28 March 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (3)
Natural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohort
Background: The extent to which changes in lung function are due to natural variability in patients with primary ciliary dyskinesia (PCD) is unknown. We aimed to assess intra-individual variability in forced expiratory volume in 1 s (FEV1) derived from spirometry to define the extent to which the observed changes were due to test variability in clinically stable PCD patients.Methods: PROVALF-PCD (Prospective Observational Multicentre Study on Variability of Lung Function in Stable PCD Patients) was a large international prospective cohort conducted in 2017–2019. We included patients aged ≥5 years who were clinically stable at two or more consecutive visits and provided spirometry-derived lung function measurements. To calculate the upper limit of normal (ULN), we fitted an unadjusted multilevel mixed-effect model, and to determine the absolute change in FEV1z-scores, we calculated the coefficient of repeatability (CR). We performed sensitivity analyses by stratifying relative change by age (adultsversuschildren), number of measurements (at least four), and time between measurements (25% between visits in stable PCD patients lie beyond the expected test variability and therefore could be considered physiologically relevant. These findings inform the selection of end-points for pulmonary intervention trials in PCD, as they suggest that FEV1is not a sensitive test for monitoring lung health in PCD.
- 28 March 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (3)
Open AccessNatural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohort
Background: The extent to which changes in lung function are due to natural variability in patients with primary ciliary dyskinesia (PCD) is unknown. We aimed to assess intra-individual variability in forced expiratory volume in 1 s (FEV1) derived from spirometry to define the extent to which the observed changes were due to test variability in clinically stable PCD patients.Methods: PROVALF-PCD (Prospective Observational Multicentre Study on Variability of Lung Function in Stable PCD Patients) was a large international prospective cohort conducted in 2017–2019. We included patients aged ≥5 years who were clinically stable at two or more consecutive visits and provided spirometry-derived lung function measurements. To calculate the upper limit of normal (ULN), we fitted an unadjusted multilevel mixed-effect model, and to determine the absolute change in FEV1z-scores, we calculated the coefficient of repeatability (CR). We performed sensitivity analyses by stratifying relative change by age (adultsversuschildren), number of measurements (at least four), and time between measurements (25% between visits in stable PCD patients lie beyond the expected test variability and therefore could be considered physiologically relevant. These findings inform the selection of end-points for pulmonary intervention trials in PCD, as they suggest that FEV1is not a sensitive test for monitoring lung health in PCD.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA1347
Effect of expressing sRaw reversibility relative to baseline or predicted values in children
Background: Expressing post-bronchodilator response (BDR) in % baseline (%B) biases the results according to baseline alteration and to the size of the subject. Reversibility is expressed as % predicted (%P) for the interrupter technique and for FEV1. Objectives: To compare the sensitivity/specificity of Raw and sRaw BDR expressed as %B or %P to distinguish children with a significant FEV1 reversibility. Methods: Monocentre retrospective study (2021 – 2023) conducted in all subjects seen for asthma, chronic cough, or unspecific symptoms without comorbidities except for possible overweight/obesity. Salbutamol was systematically administered. Results: We retrieved 2436 files with pre and post-BD sRaw and spirometry recorded in 1623 children (females 617 (38%)), age 12.4 (±2.6) years, 1465 (90%) with asthma, 179/30 overweight/obese). Baseline obstruction was detected by FEV1/FVC (n=2430), or sGaw <-1,645 z-score, or both in 584 (24%), 943 (39%) and 412 (17%) cases, respectively. FEV1 BDR was >10%P in 422 (17%) patients. ROC curve analyses for Raw (n = 2408) and sRaw showed high and similar sensitivity/specificity and AUCs for BDR %P and %B (Table). erj;64/suppl_68/PA1347/TB1 T1 TB1 BDR Raw %B Raw %p sRaw %B sRaw %p AUC (95% CI) 0.77 (0.74-0.79) 0.78 (0.76 - 0.81) 0.79 (0.77 - 0.81) 0.82 (0.80 - 0.84) Cut-off (Sensitivity/Specificity) % -33 (73/67) -45 (69/74) -35 (74/70) -56 (75/74) Conclusion: We conclude that expressing Raw or sRaw BDR as %B or %P did not change the discrimination of children with positive FEV1 BDR, but corresponds to different cut-off of which the clinical relevance needs to be further studied.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA1347
Effect of expressing sRaw reversibility relative to baseline or predicted values in children
Background: Expressing post-bronchodilator response (BDR) in % baseline (%B) biases the results according to baseline alteration and to the size of the subject. Reversibility is expressed as % predicted (%P) for the interrupter technique and for FEV1. Objectives: To compare the sensitivity/specificity of Raw and sRaw BDR expressed as %B or %P to distinguish children with a significant FEV1 reversibility. Methods: Monocentre retrospective study (2021 – 2023) conducted in all subjects seen for asthma, chronic cough, or unspecific symptoms without comorbidities except for possible overweight/obesity. Salbutamol was systematically administered. Results: We retrieved 2436 files with pre and post-BD sRaw and spirometry recorded in 1623 children (females 617 (38%)), age 12.4 (±2.6) years, 1465 (90%) with asthma, 179/30 overweight/obese). Baseline obstruction was detected by FEV1/FVC (n=2430), or sGaw <-1,645 z-score, or both in 584 (24%), 943 (39%) and 412 (17%) cases, respectively. FEV1 BDR was >10%P in 422 (17%) patients. ROC curve analyses for Raw (n = 2408) and sRaw showed high and similar sensitivity/specificity and AUCs for BDR %P and %B (Table). erj;64/suppl_68/PA1347/TB1 T1 TB1 BDR Raw %B Raw %p sRaw %B sRaw %p AUC (95% CI) 0.77 (0.74-0.79) 0.78 (0.76 - 0.81) 0.79 (0.77 - 0.81) 0.82 (0.80 - 0.84) Cut-off (Sensitivity/Specificity) % -33 (73/67) -45 (69/74) -35 (74/70) -56 (75/74) Conclusion: We conclude that expressing Raw or sRaw BDR as %B or %P did not change the discrimination of children with positive FEV1 BDR, but corresponds to different cut-off of which the clinical relevance needs to be further studied.